Outcomes of Patients with Metastatic Castration-Resistant Prostate Cancer According to Somatic Damage DNA Repair Gene Alterations

(1) Background: In literature, approximately 20% of mCRPC present somatic DNA damage repair (DDR) gene mutations, and their relationship with response to standard therapies in mCRPC is not well understood. The objective was to evaluate outcomes of mCRPC patients treated with standard therapies accor...

Descripción completa

Detalles Bibliográficos
Autores principales: Neviere, Zoé, Coquan, Elodie, Brachet, Pierre-Emmanuel, Meriaux, Emeline, Bonnet, Isabelle, Krieger, Sophie, Castéra, Laurent, Vaur, Dominique, Boulouard, Flavie, Leconte, Alexandra, Lequesne, Justine, Lelaidier, Anais, Ricou, Agathe, Joly, Florence
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030073/
https://www.ncbi.nlm.nih.gov/pubmed/35448200
http://dx.doi.org/10.3390/curroncol29040226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030073/
https://www.ncbi.nlm.nih.gov/pubmed/35448200
http://dx.doi.org/10.3390/curroncol29040226

Ejemplares similares